LEGN(传奇生物 (Legend Biotech)) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2020-12-31 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $75.00M | $68.83M | $117.00M | $285.14M | $627.24M |
| 毛利润 | $75.00M | $68.83M | $51.64M | $140.94M | $410.84M |
| 营业利润 | — | — | — | −$528.10M | −$309.50M |
| 净利润 | −$266.37M | −$403.58M | −$446.35M | −$518.25M | −$177.03M |
| 经营现金流 | −$223.00M | −$198.47M | −$201.28M | −$393.30M | −$144.00M |
| 自由现金流 | −$249.26M | −$240.66M | −$222.21M | −$413.40M | −$158.10M |
| 摊薄每股收益 | $-1.13 | $-1.43 | $-1.40 | $-1.47 | $-0.48 |